More Resources

Foundation, research center target type 1 diabetes.


La Jolla's Genomics Institute of the Novartis Research Foundation said Aug. 5 it has entered into a research agreement with the Juvenile Diabetes Research Foundation to push treatments for type 1 diabetes into the clinic at a faster pace.

The four-year program will create a diabetes drug discovery and development platform that will begin with four or five projects, according to Peter Lomedico, JDRF's Director of Industry Partnerships.

Financial details of the arrangement were not released.

COPYRIGHT 2009 CBJ, L.P. Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.

Copyright 2009 Gale, Cengage Learning. All rights reserved. Gale Group is a Thomson Corporation Company.

NOTE: All illustrations and photos have been removed from this article.


Marketplace

Learn how to distribute a press release

Try our new online printing. theupsstore.com/print
Today on Entrepreneur

Sign Up for the Latest in:
Online Business
Franchise News
Starting a Business
Sales & Marketing
Growing a Business

E-mail*

Zip Code*